Finance

Lists
Why is CVKD down 3.07%?
Dive Deeper
CVKD:NASDAQ
Cadrenal Therapeutics Inc
$0.94
-3.07%
(-0.030) 1D
Oct 2, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CVKD...
Open
$0.98
High
$1.00
Low
$0.85
Mkt. cap
3.35M
Avg. vol.
845.25K
Volume
149.60K
52-wk high
$14.64
52-wk low
$0.85
EPS
-$4.92
Beta
1.93
Shares outstanding
3.57M
No. of employees
5
Open
$0.98
High
$1.00
Low
$0.85
Mkt. cap
3.35M
Avg. vol.
845.25K
Volume
149.60K
52-wk high
$14.64
52-wk low
$0.85
EPS
-$4.92
Beta
1.93
Shares outstanding
3.57M
No. of employees
5
News stories
From web sources and news partners
About Cadrenal Therapeutics Inc
CEO-
Employees5
Founded2022
Headquarters-
SectorPharmaceutical industry
Websitecadrenal.com
Analyst ratings
Based on 2 analysts giving stock ratings to CVKD in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for CVKD in the last 3 months.
Highest
Current $0.94
$45.00 (+4,686.22%)
Average
$29.00 (+2,984.45%)
Lowest
$13.00 (+1,282.68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
$13.00
+1,282.7%
09/01/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
$45.00
+4,686.2%
07/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
688.46K
666.32K
771.51K
705.15K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.04M
2.40M
1.74M
2.63M
Operating expense
2.73M
3.07M
2.51M
3.34M
Total operating expenses
2.73M
3.07M
2.51M
3.34M
Operating income
-2.73M
-3.07M
-2.51M
-3.34M
Other non operating income
-
-
-
-
EBT including unusual items
-2.69M
-3.04M
-2.50M
-3.32M
EBT excluding unusual items
-2.69M
-3.04M
-2.50M
-3.32M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.69M
-3.04M
-2.50M
-3.32M
Net profit margin
-
-
-
-
Earnings per share
-1.31
-1.41
-1.04
-1.14
Interest and investment income
48.10K
26.12K
17.84K
17.84K
Interest expense
-
-
-
-
Net interest expenses
48.10K
26.12K
17.84K
17.84K
Depreciation and amortization charges
401.00
555.00
555.00
504.00
EBITDA
-2.73M
-3.06M
-2.51M
-3.34M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps